Release Date: 27/08/19 11:04 Summary: Cancellation of Employee Options Price Sensitive: No Download Document 107.91KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%